Orlistat and Zepbound are two U.S. Food and Drug Administration (FDA)-approved weight loss medications that work in different ...

Zepbound and Trulicity are two U.S. Food and Drug Administration (FDA)-approved medications. When used alongside diet and ...

Eli Lilly’s new Zepbound KwikPen delivers four weekly obesity-treatment doses from a single device, aiming to make injections less of a hassle. Alongside convenience, safe handling and disposal of ...

Zepbound and Mounjaro are brand-name injections with the same active ingredient: tirzepatide. Neither Zepbound nor Mounjaro is available as a generic drug. However, various forms of compounded ...

Federal regulators have agreed to review a Swiss pharmaceutical company's applications for two cheaper generic versions of ...

Weight loss drugs have dominated the headlines over the past year, and now there’s a new medication that may be the most effective one yet. About 70% of Americans are overweight, with a body mass ...

Eli Lilly will begin offering its popular new weight-loss drug Zepbound in vials—in addition to standard injection-pen devices—at about half the price of the original for certain doses. To date, ...

Zealthy announced today the launch of its enhanced virtual weight-loss care platform, designed to simplify access to provider-guided obesity treatment through integrated telehealth services, insurance ...

Millions of Medicare beneficiaries will gain access to obesity drugs for the first time starting Wednesday under CMS’ temporary Bridge program, a federal initiative designed to expand GLP-1 obesity ...

Zepbound is a once-weekly injection used to help adults with weight management or obstructive sleep apnea. Doctors typically start you on a low dose and slowly increase it over time to find the right ...

Eli Lilly plans to release initial results from several late-stage clinical trials on its experimental once-daily obesity pill, orforglipron, this year. The trial results are among the pharmaceutical ...